Intensive research is being performed at the School of life sciences on drug responsive epilepsy patients and schizophrenia, lithium response in bipolar disorder, metformin and Sulfonylurea drug response in type 2 diabetese patients resulting in the development of assays for pharmacogenomic diagnostics with the support of TIFAC core.